772299-15-7Relevant articles and documents
Platelet aggregation inhibiting and anticoagulant effects of oligoamines, I: N-(4-piperidinyl)methanamines
Rehse,Werner
, p. 505 - 515 (1986)
In concentrations of some μmol/l, 4-aminomethyl-4-phenylpiperidines suitably aralkylated at position 1 inhibit the platelet aggregation induced by collagen. The most potent compound 10 shows an IC50 of 5.5 · 106 mol/l. The metabolism of arachidonic acid in platelets remains unchanged. At a concentration of 10-4 mol/l 10 also depresses the fibrin formation induced by thromboplastin to 25 percent of normal.
Opioids and efflux transporters. Part 1: P-Glycoprotein substrate activity of N-substituted analogs of meperidine
Mercer, Susan L.,Hassan, Hazem E.,Cunningham, Christopher W.,Eddington, Natalie D.,Coop, Andrew
, p. 1160 - 1162 (2007/10/03)
P-Glycoprotein (P-gp) is an efflux transporter which is up-regulated at the blood-brain barrier in both morphine- and oxycodone-tolerant rats. Numerous studies have shown that many clinically employed opioid analgesics are substrates for P-gp, suggesting that up-regulation of P-gp may contribute to the development of central tolerance to opioids. The studies herein focus on the development of SAR for P-gp substrate activity in the meperidine series of compounds, and show that a meperidine analog of greater potency, N-phenylbutyl-N-normeperidine, has low activity as a P-gp substrate and has the potential to be utilized as a tool to study the contribution of P-gp to the development of central tolerance to opioids.
